Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
451.80M | 368.17M | 303.43M | 252.02M | 203.22M | Gross Profit |
328.82M | 261.04M | 215.64M | 184.16M | 149.96M | EBIT |
12.23M | -16.75M | 5.12M | 38.76M | -20.42M | EBITDA |
24.41M | -6.82M | 5.12M | 31.95M | -18.15M | Net Income Common Stockholders |
424.38M | -21.63M | -6.70M | -8.09M | -44.23M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
255.49M | 296.22M | 255.61M | 254.60M | 61.09M | Total Assets |
1.17B | 558.74M | 483.84M | 344.36M | 115.56M | Total Debt |
71.92M | 72.08M | 76.60M | 53.91M | 424.90M | Net Debt |
-105.43M | -149.69M | -174.13M | -200.69M | 363.82M | Total Liabilities |
139.34M | 149.09M | 145.45M | 82.27M | 460.17M | Stockholders Equity |
1.01B | 354.33M | 269.52M | 197.03M | -344.61M |
Cash Flow | Free Cash Flow | |||
69.06M | 78.98M | 50.25M | -1.67M | -10.29M | Operating Cash Flow |
74.32M | 84.60M | 58.01M | 3.36M | -6.49M | Investing Cash Flow |
-55.65M | -95.06M | -76.55M | -5.03M | -3.81M | Financing Cash Flow |
-61.67M | -19.29M | 16.23M | 195.29M | 51.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $6.63B | 13.92 | 58.14% | ― | 22.72% | ― | |
76 Outperform | $7.88B | 44.78 | 39.29% | 0.13% | 14.29% | 151.38% | |
76 Outperform | $7.30B | 98.41 | 25.23% | ― | 18.63% | -55.09% | |
69 Neutral | $6.31B | 235.54 | -24.39% | ― | 16.49% | -279.46% | |
60 Neutral | $10.95B | 10.52 | -7.07% | 3.00% | 7.30% | -12.04% | |
59 Neutral | $6.87B | ― | -0.20% | ― | 30.93% | 99.45% | |
51 Neutral | $3.93B | ― | -32.59% | ― | 8.56% | 13.34% |
On April 21, 2025, Clearwater Analytics completed its acquisition of Enfusion, valued at approximately $1.5 billion. This strategic move positions Clearwater as the first unified, cloud-native front-to-back platform for institutional investors, enhancing its market position by integrating Enfusion’s front-office capabilities with its existing middle and back-office solutions. The acquisition is expected to expand Clearwater’s total addressable market and international presence, offering seamless integration and operational efficiency across asset classes and geographies.
Spark’s Take on CWAN Stock
According to Spark, TipRanks’ AI Analyst, CWAN is a Outperform.
Clearwater Analytics Holdings is well-positioned with strong financial performance and strategic growth initiatives. Key strengths include robust revenue growth and strategic acquisitions, although technical indicators suggest caution with bearish momentum. Valuation appears fair, and the company’s strategic outlook remains positive despite operational profitability challenges.
To see Spark’s full report on CWAN stock, click here.
On March 11, 2025, Clearwater Analytics Holdings announced two strategic acquisitions, Beacon and Blackstone’s Bistro, to enhance its investment management technology platform. The acquisition of Beacon, a leader in cross-asset class modeling and risk analytics, and Bistro, a portfolio visualization software, aims to provide a unified, real-time view of portfolios, thereby improving risk management and operational efficiency for institutional investors. This move positions Clearwater as a comprehensive solution provider in the investment management industry, promising enhanced transparency and decision-making capabilities for stakeholders.
On February 26, 2025, Clearwater Analytics Holdings announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its proposed acquisition of Enfusion. This expiration satisfies a key condition for the transaction, which is expected to close in the second quarter of 2025, pending customary closing conditions and Enfusion shareholder approval. The acquisition aims to integrate Enfusion’s operations and technology with Clearwater’s, potentially enhancing their competitive position and growth opportunities in the investment management industry.